📰 Mindset Pharma News
Page 3 - Mindset Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mindset Pharma. Real-time updates on events, politics, business and more.
July 17, 2023
Clinical-stage psychedelics company Reunion Neuroscience (NASDAQ: REUN) is about to close on its take-private transaction with MPM BioImpact affiliates, as shareholders voted for a special resolution approving the proposed arrangement plan on July 12.
July 7, 2023
Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...
June 28, 2023
A first-of-its-kind trial testing a novel psilocin-based drug for major depressive disorder (MDD) has been approved by the UK MHRA.
June 27, 2023
Echelon Capital Markets analyst Stefan Quenneville in a recent report reiterated a “Speculative Buy” rating on Mindset Pharma stock.
June 27, 2023
Commercial trial to treat major depressive disorder with psychedelic drugs given green light by MHRA
June 20, 2023
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 12, 2023 AND MANAGEMENT INFORMATION CIRCULAR JUNE 13, 2023 ... | June 20, 2023
June 2, 2023
Analyst Says Pharma Co. Meaningfully Undervalued
June 1, 2023
31.05.2023 - MONTREAL, QC / ACCESSWIRE / May 31, 2023 / St-Georges Eco-Mining Corp. (CSE:SX)(OTCQB:SXOOF)(FSE:85G1) would like to report that Mr. Frank Dumas has resigned from his position as a director and Chief Operating Officer of the Company. Effective June ...
June 1, 2023
Montréal, 1, 2023 - St-Georges Eco-Mining Corp. would like to report that Mr. Frank Dumas has resigned from his position as a director and Chief Operating Officer of the Company. Effective 1, 2023, Frank will assume the duties of the newly... - Veroeffentlicht am 01.06.2023
May 31, 2023
Echelon Capital Markets analyst Stefan Quenneville reiterated a “Speculative Buy” rating and $1.25 target price on Mindset Pharma in a Wednesday report to clients.